Pitt Innovators Find Clinical & Commercial Success in Immuno-Oncology
Dr. Joseph Glorioso's oncolytic virus technology was licensed by Oncorus Inc., which last fall raised $61.4 million in venture financing.
January 18, 2017
January 13, 2017
January 11, 2017
January 5, 2017
January 4, 2017